Rachel Zegler is opening up about the intense backlash she faced during the rollout of Disney’s live-action Snow White, ...

Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity ...

Hims & Hers Health (HIMS) has made a major change in its PR function with the hiring of Kathryn Beiser, who has served Lilly (LLY) as the weight loss drugmaker’s chief communications officer for five ...

Lost” star Matthew Fox, who stepped back from acting for more than a decade despite starring in one of TV’s biggest hits, is ...

Pink may be preparing for a surprising new chapter in her career, and it could involve daytime television. With Kelly ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Eli Lilly commits $3 billion to China expansion spanning the next ten years Funding targets orforglipron manufacturing, the company’s oral GLP-1 therapy for weight management Marketing authorization ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

A common refrain since GLP-1 weight-loss drugs hit the market is that the price of treatments has led many employers to hesitate about providing access to the drugs through company health plans. In ...

Eli Lilly is a market darling at the moment because of its industry-leading GLP-1 drugs. The stock looks priced for perfection despite a well-known drug cycle. That's good news, but investors are well ...

Halle Berry is speaking out about why she felt the need to go silent with the press for a decade. Berry, 59, opened up about her decision in a recent interview with The Cut, where the actress also ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now. There’s been huge hype around AI’s potential for drug discovery. But at Eli Lilly, ...